Cell softening in malignant progression of human lung cancer cells by activation of receptor tyrosine kinase AXL

Abstract To study the role of cell softening in malignant progression, Transwell assay and atomic force microscope were used to classify six human non-small cell lung cancer cell lines into two groups: a high motility-low stiffness (HMLS) group and a low motility-high stiffness (LMHS) group. We foun...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Keisuke Iida, Ryo Sakai, Shota Yokoyama, Naritaka Kobayashi, Shodai Togo, Hiroshi Y. Yoshikawa, Anchalee Rawangkan, Kozue Namiki, Masami Suganuma
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
R
Q
Acceso en línea:https://doaj.org/article/a557dc64c7504b61bb974bc013633a1e
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:a557dc64c7504b61bb974bc013633a1e
record_format dspace
spelling oai:doaj.org-article:a557dc64c7504b61bb974bc013633a1e2021-12-02T15:05:40ZCell softening in malignant progression of human lung cancer cells by activation of receptor tyrosine kinase AXL10.1038/s41598-017-18120-42045-2322https://doaj.org/article/a557dc64c7504b61bb974bc013633a1e2017-12-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-18120-4https://doaj.org/toc/2045-2322Abstract To study the role of cell softening in malignant progression, Transwell assay and atomic force microscope were used to classify six human non-small cell lung cancer cell lines into two groups: a high motility-low stiffness (HMLS) group and a low motility-high stiffness (LMHS) group. We found a significant role of activity of the AXL receptor tyrosine kinase, which belongs to the TAM (Tyro3, AXL, Mer) family, in the stimulation of motility and cell softening. HMLS cells expressed higher AXL levels than LMHS cells and contained phosphorylated AXL. H1703 LMHS cells transfected with exogenous AXL exhibited increased motility and decreased stiffness, with low levels of actin stress fibre formation. Conversely, the AXL-specific inhibitor R428 and AXL-targeting siRNA reduced motility and increased stiffness in H1299 HMLS cells. Knockdown of AXL stimulated actin stress fibre formation, which inhibited tumour formation in a mouse xenograft model. The Ras/Rac inhibitor SCH 51344, which blocks disruption of actin stress fibres, exerted similar effects to AXL inactivation. We therefore propose that the Ras/Rac pathway operates downstream of AXL. Thus, AXL activation-induced cell softening promotes malignant progression in non-small cell lung cancer and represents a key biophysical property of cancer cells.Keisuke IidaRyo SakaiShota YokoyamaNaritaka KobayashiShodai TogoHiroshi Y. YoshikawaAnchalee RawangkanKozue NamikiMasami SuganumaNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-11 (2017)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Keisuke Iida
Ryo Sakai
Shota Yokoyama
Naritaka Kobayashi
Shodai Togo
Hiroshi Y. Yoshikawa
Anchalee Rawangkan
Kozue Namiki
Masami Suganuma
Cell softening in malignant progression of human lung cancer cells by activation of receptor tyrosine kinase AXL
description Abstract To study the role of cell softening in malignant progression, Transwell assay and atomic force microscope were used to classify six human non-small cell lung cancer cell lines into two groups: a high motility-low stiffness (HMLS) group and a low motility-high stiffness (LMHS) group. We found a significant role of activity of the AXL receptor tyrosine kinase, which belongs to the TAM (Tyro3, AXL, Mer) family, in the stimulation of motility and cell softening. HMLS cells expressed higher AXL levels than LMHS cells and contained phosphorylated AXL. H1703 LMHS cells transfected with exogenous AXL exhibited increased motility and decreased stiffness, with low levels of actin stress fibre formation. Conversely, the AXL-specific inhibitor R428 and AXL-targeting siRNA reduced motility and increased stiffness in H1299 HMLS cells. Knockdown of AXL stimulated actin stress fibre formation, which inhibited tumour formation in a mouse xenograft model. The Ras/Rac inhibitor SCH 51344, which blocks disruption of actin stress fibres, exerted similar effects to AXL inactivation. We therefore propose that the Ras/Rac pathway operates downstream of AXL. Thus, AXL activation-induced cell softening promotes malignant progression in non-small cell lung cancer and represents a key biophysical property of cancer cells.
format article
author Keisuke Iida
Ryo Sakai
Shota Yokoyama
Naritaka Kobayashi
Shodai Togo
Hiroshi Y. Yoshikawa
Anchalee Rawangkan
Kozue Namiki
Masami Suganuma
author_facet Keisuke Iida
Ryo Sakai
Shota Yokoyama
Naritaka Kobayashi
Shodai Togo
Hiroshi Y. Yoshikawa
Anchalee Rawangkan
Kozue Namiki
Masami Suganuma
author_sort Keisuke Iida
title Cell softening in malignant progression of human lung cancer cells by activation of receptor tyrosine kinase AXL
title_short Cell softening in malignant progression of human lung cancer cells by activation of receptor tyrosine kinase AXL
title_full Cell softening in malignant progression of human lung cancer cells by activation of receptor tyrosine kinase AXL
title_fullStr Cell softening in malignant progression of human lung cancer cells by activation of receptor tyrosine kinase AXL
title_full_unstemmed Cell softening in malignant progression of human lung cancer cells by activation of receptor tyrosine kinase AXL
title_sort cell softening in malignant progression of human lung cancer cells by activation of receptor tyrosine kinase axl
publisher Nature Portfolio
publishDate 2017
url https://doaj.org/article/a557dc64c7504b61bb974bc013633a1e
work_keys_str_mv AT keisukeiida cellsofteninginmalignantprogressionofhumanlungcancercellsbyactivationofreceptortyrosinekinaseaxl
AT ryosakai cellsofteninginmalignantprogressionofhumanlungcancercellsbyactivationofreceptortyrosinekinaseaxl
AT shotayokoyama cellsofteninginmalignantprogressionofhumanlungcancercellsbyactivationofreceptortyrosinekinaseaxl
AT naritakakobayashi cellsofteninginmalignantprogressionofhumanlungcancercellsbyactivationofreceptortyrosinekinaseaxl
AT shodaitogo cellsofteninginmalignantprogressionofhumanlungcancercellsbyactivationofreceptortyrosinekinaseaxl
AT hiroshiyyoshikawa cellsofteninginmalignantprogressionofhumanlungcancercellsbyactivationofreceptortyrosinekinaseaxl
AT anchaleerawangkan cellsofteninginmalignantprogressionofhumanlungcancercellsbyactivationofreceptortyrosinekinaseaxl
AT kozuenamiki cellsofteninginmalignantprogressionofhumanlungcancercellsbyactivationofreceptortyrosinekinaseaxl
AT masamisuganuma cellsofteninginmalignantprogressionofhumanlungcancercellsbyactivationofreceptortyrosinekinaseaxl
_version_ 1718388785561993216